Mentorship is a cornerstone of the infrastructure supporting global health. Transferring knowledge, developing skills and cultivating a supportive professional environment among researchers and clinicians around the world are key to achieving health equity on a global scale.
For example, most people in Africa would have been fully vaccinated against COVID-19 by now if the patented knowledge about the vaccine technology were shared with African scholars and local pharmaceutical companies to produce a generic version. As of October 2023, although over 95% of available doses have been used, less than 52% of the population is fully vaccinated.
However, researchers from the Global South – countries in the regions of Africa, Latin America, the Caribbean, Asia and Oceania with limited resources and a lower standard of living – face challenges that impede effective mentorship.
One reason is that mentorship is often hierarchical. Mentors, typically from the Global North, or high-income countries, are often seen as more credible than mentees who are mostly from the Global South. Mentees are often described as inexperienced, requiring training and guidance. While mentorships are by definition hierarchical, researchers from the Global South are assumed to lack the skills to adequately implement health programs or conduct research and would benefit from greater experience of scholars from the Global North.
Hierarchical relationships, especially those between people from the Global North and Global South, are not mutually beneficial or fair. Based on our personal experiences and research as public health researchers, statisticians and social scientists, we believe that cultural humility and equitable partnerships are key to effective global health projects.
Scholars from the Global North and Global South can learn from each other. Decolonizing mentorship in global health, or addressing the historical power imbalances between researchers from the Global North and Global South, can help advance global health for all.
Challenges in global health research
Some scholars have defined global health as “collaborate transnational research and action for promoting health for all.” Historically, however, the concept of global health is rooted in Western ideas of who is considered human. Europeans are depicted as the norm or standard, while non-Europeans are depicted as strange or inferior.
This hierarchy is omnipresent in knowledge exchange and health resource allocation between the Global North and Global South. For example, the European Union rejected proposals that would have allowed African countries, mostly former European colonies, to manufacture generic COVID-19 vaccines when the 55 million doses the West donated expired in February 2022.
Scholarly collaborations between the Global North and Global South are also unequal in power. Notably, most of the major global health institutes are located in the Global North, although the greatest burden of diseases such as HIV and malaria is centered in the Global South. Conferences where researchers gather to learn about new innovations in their field and to network are typically located in high-income countries. Few Global South scholars are able to attend because of travel restrictions and financial constraints, leaving them without guidance on how to navigate and significantly contribute to the field.
For example, several scholars from the Global South have noted how visa restrictions and fees affected their ability to attend global health conferences in high-income countries. But even having a visa does not guarantee easy entry. Winifred Byanyima, executive director of the Joint United Nations Programme on HIV/AIDS, who is originally from Uganda, was traveling to Montreal, Canada, to attend the world’s largest AIDS conference in 2022. She was almost denied boarding a plane, however, despite her high-level position.
Mentorship is a cornerstone of the infrastructure supporting global health. Transferring knowledge, developing skills and cultivating a supportive professional environment among researchers and clinicians around the world are key to achieving health equity on a global scale.
For example, most people in Africa would have been fully vaccinated against COVID-19 by now if the patented knowledge about the vaccine technology were shared with African scholars and local pharmaceutical companies to produce a generic version. As of October 2023, although over 95% of available doses have been used, less than 52% of the population is fully vaccinated.
However, researchers from the Global South – countries in the regions of Africa, Latin America, the Caribbean, Asia and Oceania with limited resources and a lower standard of living – face challenges that impede effective mentorship.
One reason is that mentorship is often hierarchical. Mentors, typically from the Global North, or high-income countries, are often seen as more credible than mentees who are mostly from the Global South. Mentees are often described as inexperienced, requiring training and guidance. While mentorships are by definition hierarchical, researchers from the Global South are assumed to lack the skills to adequately implement health programs or conduct research and would benefit from greater experience of scholars from the Global North.
A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for prescription drugs has been revived by a federal appeals court
A sports nutritionist in Australia says iron pills can help, but you have to take them correctly to see results. In an article for the Conversation on Tuesday, Alannah McKay from Australian Catholic University broke down the ins and outs of iron supplements. “The body needs iron to make new red blood cells, and to support energy production, the immune system and cognitive function,” McKay wrote. She noted that iron deficiency can cause symptoms including fatigue, weakness and reduced concentration. While most Americans get sufficient iron through diet, certain groups are at higher risk for deficiency. These include menstruating or
A Johnson & Johnson subsidiary filed for bankruptcy for a third time on Friday as the healthcare giant seeks to advance an approximately $10 billion proposed settlement
A revolutionary new approach to weight loss could rise above medications like Ozempic and Wegovy. By combining the appetite-suppressing hormone GLP-1 with special molecules that zero in on the brain’s appetite control center, this “Trojan horse” therapy achieved remarkable weight loss in mice – up to twice as much as GLP-1 alone in some cases. The drug co-developed by scientists at the University of Copenhagen and Novo Nordisk smuggles in molecules that directly regulate hunger alongside GLP-1. While currently approved GLP-1 medications just make people feel fuller, this two-pronged offensive strikes the appetite at its neurological roots. “The effect of